Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Varian to market cancer therapy device in US:

This article was originally published in Clinica

Executive Summary

Varian Medical Systems has received marketing clearance from the FDA for its Millennium MLC-120 multileaf collimator, a beam-shaping device which concentrates the radiation energy on the tumour instead of the surrounding healthy tissue. It is suitable for small, irregularly shaped lesions which occur on the head or neck, according to the Palo Alto, California-based company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078565

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel